A detailed history of First Command Advisory Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 2,026 shares of LLY stock, worth $1.53 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,026
Previous 2,025 0.05%
Holding current value
$1.53 Million
Previous $1.83 Million 2.13%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.05%
2,026 $1.79 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $60,164 - $75,450
83 Added 4.27%
2,025 $1.83 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $338,738 - $453,184
572 Added 41.75%
1,942 $1.51 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $7,877 - $9,286
15 Added 1.11%
1,370 $798,000
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $589,018 - $812,051
1,355 New
1,355 $727,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Command Advisory Services, Inc. Portfolio

Follow First Command Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Advisory Services, Inc. with notifications on news.